Thus, no curative treatment has been approved for silicosis, and the currently used drugs cannot reverse the disease process.1,43,44 Recently, using transcriptome and metabolome datasets, our previous studies revealed several potential targets, such as FGF10, MUC5AC, PGD2 and TXA2. This evidence concerns the gene FGF10 and silicosis.